<DOC>
	<DOCNO>NCT01144312</DOCNO>
	<brief_summary>The aim study characterize pharmacokinetics fentanyl Living Donor Liver Transplantation ( LDLT ) , use population pharmacokinetic analysis non linear mixed effect model .</brief_summary>
	<brief_title>Population Pharmacokinetics Fentanyl Patients Undergoing Living Donor Liver Transplantation</brief_title>
	<detailed_description>Patients receive initial intravenous bolus fentanyl 100 μg infuse variable rate range 250 400 μg/hr . Arterial blood sample ( 3ml ) take immediately start infusion ( baseline ) , schedule time coincident laboratory test surgery follow . In pre-anhepatic phase , blood take 10min , 30min , 1hr , 3hr , 5hr clamp hepatic blood supply venous drainage , star anhepatic phase , blood take 5 min , 10 min , 30 min , 60 min , 90 min , 2hr vessel reconnected new liver . In neo-hepatic phase , blood take 5min , 10min , 30min , 60min , 90min , 2hr , 3hr , 5hr fentanyl-infusion stop , 0hr , 1hr , 3hr , 5hr , 8hr , 12hr , 24hr immediately stop infusion . Samples collect tube contain heparin anticoagulant immediately place ice . After centrifugation 8 min 1800 g , plasma transfer cryovial stored -70°C assay .</detailed_description>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>Patients 19 65 year age Over 45kg weight Written Informed consent Patients receive liver graft live donor ( ASA PS III IV ) Patients renal dysfunction Patients Fulminant hepatic failure Patients participate clinical trial within 2 month Unable Unwilling give inform consent Abnormal test result clinical significance</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>LDLT</keyword>
</DOC>